A 3-year-old boy from North India presents with recurrent episodes of hyperammonemia, developmental delay, and hepatomegaly. Genetic testing reveals a deficiency in argininosuccinate synthetase. Regarding the metabolic consequences of this enzyme deficiency, all of the following are true EXCEPT:

Explanation

## Argininosuccinate Synthetase Deficiency (Citrullinemia Type I) ### Clinical and Biochemical Context **Key Point:** Argininosuccinate synthetase (Step 4) catalyzes: Citrulline + Aspartate → Argininosuccinate. Deficiency of this enzyme causes **citrullinemia type I**, one of the primary urea cycle disorders. **High-Yield:** The block at Step 4 prevents the formation of argininosuccinate and downstream arginine, leading to: - **Citrulline accumulation and massive urinary excretion** (diagnostic finding) - **Hyperammonemia** (ammonia cannot proceed through the cycle) - **Low plasma arginine** (not elevated — arginine is NOT produced) ### Pathophysiology of the Block ```mermaid flowchart TD A[Carbamoyl phosphate + Ornithine]:::outcome --> B[Citrulline]:::outcome B --> C{Argininosuccinate Synthetase}:::decision C -->|Normal| D[Argininosuccinate]:::outcome D --> E[Arginine]:::outcome E --> F[Urea + Ornithine]:::outcome C -->|Deficient| G[Citrulline accumulates]:::urgent G --> H[Urinary citrulline ↑↑↑]:::outcome G --> I[Plasma citrulline ↑↑]:::outcome I --> J[Arginine NOT produced ↓]:::urgent B --> K[Aspartate cannot condense]:::outcome K --> L[Ammonia accumulates]:::urgent ``` ### Correct Statements **Statement 1 (Correct):** Citrulline accumulates proximal to the enzymatic block and is excreted in massive amounts in urine — this is the diagnostic hallmark of citrullinemia type I. **Statement 3 (Correct):** The block prevents ammonia from being converted to urea. Carbamoyl phosphate and ammonia are still produced, but the cycle cannot proceed beyond citrulline, resulting in severe hyperammonemia. **Statement 4 (Correct):** Aspartate normally condenses with citrulline (via argininosuccinate synthetase) to form argininosuccinate. When the enzyme is deficient, aspartate cannot be incorporated into the urea cycle and may accumulate. ### The Incorrect Statement **Warning:** Plasma arginine levels are **LOW or NORMAL**, NOT elevated. The defect blocks the production of arginine (Step 4 → 5 → 6). Arginine is an essential amino acid in infants and becomes conditionally essential in urea cycle disorders. The lack of arginine production, combined with ongoing consumption for protein synthesis, results in arginine deficiency — not excess. **Clinical Pearl:** Arginine supplementation is a key therapeutic strategy in citrullinemia type I because endogenous production is blocked and arginine is needed for: - Protein synthesis - Creatine synthesis - Nitric oxide synthesis - Immune function ### Diagnostic and Therapeutic Summary | Feature | Finding | | --- | --- | | Plasma citrulline | ↑↑↑ (markedly elevated) | | Urinary citrulline | ↑↑↑ (massive excretion) | | Plasma ammonia | ↑↑ (hyperammonemia) | | Plasma arginine | ↓ (LOW, not elevated) | | Plasma aspartate | May be ↑ (cannot be utilized) | | Treatment | Protein restriction, arginine supplementation, sodium benzoate | **Mnemonic:** **CUA** — **C**itrulline ↑↑↑, **U**rea ↓, **A**rginine ↓ (in citrullinemia type I).